- Open Access
Erratum to: Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy?
© The Author(s) 2017
- Received: 27 June 2017
- Accepted: 27 June 2017
- Published: 7 July 2017
The original article was published in Allergy, Asthma & Clinical Immunology 2016 12:11
After publication of the article  it was brought to our attention that the incorrect length of needle was used for one of the epinephrine auto-injectors (EAI), Jext®. The length of the needle of the Jext® 0.15 mg is not 15.7 mm as mentioned in the paper, but 13 mm. After correcting the needle length for Jext®, the results of the study do not change aside for those involving Jext®. The results of the primary outcome variable for Jext® are now the same as the other high pressure EAIs (HPEAIs) and do not lead to intra-osseous injections 38% but 11% between 15 and 30 kg. This is the same risk as the Epipen® and the Auvi-Q®.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Dreborg S, Wen X, Kim L, Tsai G, Nevis I, Potts R, Chiu J, Dominic A, Kim H. Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy? Allergy Asthma Clin Immunol. 2016;12:1. doi:10.1186/s13223-016-0110-8.View ArticleGoogle Scholar